R2-GemOx regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R2-GemOx regimen, covering 2022-03-07 to 2022-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL [Phase 2]